OBESITY, ABDOMINAL
Clinical trials for OBESITY, ABDOMINAL explained in plain language.
Never miss a new study
Get alerted when new OBESITY, ABDOMINAL trials appear
Sign up with your email to follow new studies for OBESITY, ABDOMINAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Fatty liver fix? growth hormone drug shows promise in early trial
Disease control CompletedThis study tested a drug called tesamorelin, which boosts growth hormone, in 51 obese adults with nonalcoholic fatty liver disease (NAFLD). The goal was to see if it could lower liver fat and improve liver inflammation and scarring. Participants received either tesamorelin or a p…
Matched conditions: OBESITY, ABDOMINAL
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Soda ban at work helps shrink waistlines, study finds
Disease control CompletedThis study tested whether removing sugary drinks from workplace sales and offering brief counseling could help employees lose belly fat and improve insulin sensitivity. Over 600 full-time workers who drank at least three sugary beverages per week took part. Results showed changes…
Matched conditions: OBESITY, ABDOMINAL
Phase: NA • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated May 14, 2026 12:03 UTC